Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia

Kiđemet-Piskač, Spomenka and Babić Leko, Mirjana and Blažeković, Antonela and Langer Horvat, Lea and Klepac, Nataša and Sonicki, Zdenko and Kolenc, Danijela and Hof, Patrick R. and Boban, Marina and Mimica, Ninoslav and Borovečki, Fran and Šimić, Goran (2018) Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia. CNS Neuroscience & Therapeutics, 24 (8). pp. 734-740. ISSN 1755-5930

[img] PDF - Published Version
Download (750kB)

Abstract

BACKGROUND: The diagnosis of either Alzheimer's disease (AD) or vascular dementia (VaD) is still largely based on clinical guidelines and exclusion of other diseases that may lead to dementia. ----- AIMS: In this study, we assessed whether the use of sensitive and specific biomarkers such as phosphorylated tau proteins could contribute to an earlier and more accurate diagnosis of AD and VaD, as well as to their differentiation. ----- MATERIAL AND METHODS: A total of 198 patients, of which 152 had AD, 28 VaD, and 18 were healthy controls (HC), were included in the analyses. We analyzed cerebrospinal fluid (CSF) levels of total tau protein (t-tau), tau protein phosphorylated at threonine 231 (p-tau231), and factor score (FS) determined by combination of p-tau231 and Mini-Mental State Examination (MMSE) in patients with AD and VaD, as well as in HC. We tested the diagnostic accuracy of these biomarkers in the CSF and FS (p-tau231, MMSE) in differentiating AD from VaD and HC. ----- RESULTS: Total tau levels were significantly elevated in subjects with AD compared to HC, as well as in VaD subjects compared to HC. ----- DISCUSSION: p-tau231 levels were significantly higher in patients with ADvsHC as well in patients with VaD vsHC. p-tau231 levels did not distinguish AD from VaD patients. Importantly, FS(p-tau231 and MMSE) showed statistically significant differences in the distribution of subjects with AD and VaD. ----- CONCLUSION: These results indicate that FS (p-tau231 and MMSE) has a strong potential to provide an early distinction between AD and VaD.

Item Type: Article
MeSH: Aged ; Alzheimer Disease/cerebrospinal fluid ; Alzheimer Disease/diagnosis ; Biomarkers/cerebrospinal fluid ; Dementia, Vascular/cerebrospinal fluid ; Diagnosis, Differential ; Female ; Humans ; Male ; Mental Status and Dementia Tests ; Middle Aged ; Phosphorylation ; ROC Curve ; Retrospective Studies ; Statistics, Nonparametric ; tau Proteins/cerebrospinal fluid
Departments: Hrvatski institut za istraživanje mozga
Katedra za anatomiju i kliničku anatomiju
Katedra za medicinsku statistiku, epidemiologiju i medicinsku informatiku
Katedra za neurologiju
Katedra za psihijatriju i psihološku medicinu
Depositing User: Kristina Berketa
Status: Published
Creators:
CreatorsEmail
Kiđemet-Piskač, SpomenkaUNSPECIFIED
Babić Leko, MirjanaUNSPECIFIED
Blažeković, AntonelaUNSPECIFIED
Langer Horvat, LeaUNSPECIFIED
Klepac, NatašaUNSPECIFIED
Sonicki, ZdenkoUNSPECIFIED
Kolenc, DanijelaUNSPECIFIED
Hof, Patrick R.UNSPECIFIED
Boban, MarinaUNSPECIFIED
Mimica, NinoslavUNSPECIFIED
Borovečki, FranUNSPECIFIED
Šimić, GoranUNSPECIFIED
Date: August 2018
Date Deposited: 21 Oct 2019 11:05
Last Modified: 26 Aug 2020 07:29
Subjects: /
Related URLs:
URI: http://medlib.mef.hr/id/eprint/3461

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year